InvestorNewsBreaks – Friendable Inc. (FDBL) Working to Make Fan Pass a Household Name
December 20, 2021
Friendable’s (OTC: FDBL) Fan Pass platform has seen massive growth since its launch in July 2020, with thousands of established and independent artists signing up in the last 12 months. The platform has reached multiple significant milestones this year, including the launch of an updated version, the publication of new mobile applications in both the […]
Mining Developer StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Builds Gold & Silver Assets as Analysts Eye Inflation Trends
December 20, 2021
Mineral property exploration company StraightUp Resources is building a portfolio of gold and silver mining options in Canada, the United States and Peru The company has been particularly focused thus far on its options in Ontario, Canada’s prolific Red Lake mining district, where airborne surveys and follow up ground investigation have been completed to analyze […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces General Meeting Voting, Publication of Key Article on CBN as Possible Glaucoma Treatment
December 20, 2021
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, held its general meeting on Dec. 17, 2021, and approved the election of all director nominees. Those elected will hold office until the next annual shareholder meeting or until their successors are elected or appointed. The company also noted that […]
ISW Holdings Inc. (ISWH) Reports Record Revenue, Forecasts $7M Per Month
December 20, 2021
NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) — via InvestorWire — ISW Holdings Inc. (OTC: ISWH) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication and forward-looking statements, please visit: https://nnw.fm/YrdIL Developments are translating to revenue and […]
InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Focused on Improving Patient Outcomes, Lowering Overall Health Care Costs
December 17, 2021
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is celebrating the achievement of key milestones this year, which include an agreement with Abbott Diagnostics to establish in-store kiosks that utilize Avricore’s platform. This builds on an agreement with the Shoppers Drug Mart pharmaceutical chain that makes its platform accessible to patients across Canada. Avricore’s HealthTab(TM) platform is […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Announces New CEO
December 17, 2021
StraightUp Resources (CSE: ST) (OTCQB: STUPF), a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America, has announced the appointment of a new CEO: Rod Husband. An accomplished entrepreneur and economic geologist with more than 30 years of experience in the international commodity and finance […]
Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Is ‘One to Watch’
December 17, 2021
Eat Well’s leadership team has founded, built, and sold a previous multi-hundred-million-dollar plant-based food company The company’s vertical integration offers an opportunity to invest in the value chain from seed-to-market, rather than a single brand or segment Eat Well’s portfolio of companies are uniquely positioned at the epicenter of grower relationships, supply chains and innovation […]
FingerMotion Inc. (FNGR) Continues To Drive Customer and Shareholder Value Through Innovative Technology
December 16, 2021
FingerMotion currently targets over one billion users within the Chinese market The company is a crucial player within the telecommunications and insurtech markets, which are projected to post CAGRs of 5% and 48% from 2020-2025 and 2021-2028, respectively Progress is seen by the company’s move to form a collaborative alliance with Munich Re, through JiuGe, […]
Marijuana Company of America Inc. (MCOA) Achieving Growth Through Acquisitions and Strategic Partnerships
December 16, 2021
MCOA just posted its highest quarterly revenue yet in Q3 2021, attributed to the cDistro acquisition, which was completed towards the end of Q2 2021 MCOA looks forward to having another record-breaking quarter in Q4, 2021, primarily attributed to additional benefits of the cDistro acquisition, along with strategic partnerships with key players within the legal […]
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Significant Milestone That Brings iSTRYM Closer to Commercial Deployment
December 16, 2021
Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, today announced that the company and its digital therapeutics technology, iSTRYM, have been certified as Health Insurance Portability and Accountability Act (“HIPAA”) compliant. HIPAA compliance certification reflects MINDCURE’s commitment to achieving the highest standards of […]
InvestorNewsBreaks – Splash Beverage Group Inc. (NYSE American: SBEV) Announces TraDigital IR as Digital Communication Provider
December 15, 2021
Splash Beverage (NYSE American: SBEV), an innovator in the beverage industry with a growing portfolio of alcoholic and nonalcoholic beverage brands, is partnering with TraDigital IR, a leading financial and digital media communications firm, to strengthen its financial marketing presence and establish new relationships in the investment community. TraDigital is a leading financial and digital […]
InvestorNewsBreaks – StraightUp Resources Inc.’s (CSE: ST) (OTCQB: STUPF) Exciting Portfolio Showcased in Latest Episode of ‘Bell2Bell’ Podcast
December 15, 2021
StraightUp Resources (CSE: ST) (OTCQB: STUPF) was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Mark Brezer, StraightUp’s CEO, president and director, joined the latest episode to discuss the company’s business model and its intriguing portfolio of mineral property assets in North […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Notice of Allowance from U.S. Patent Office for Exclusive Anxiety Disorder Treatment
December 15, 2021
Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has been awarded a Notice of Allowance from the U.S. Patent and Trademark Office (“USPTO”). The award is for CYBN’s patent application related to CYB004, an investigational deuterated psychedelic tryptamine compound developed for the potential treatment of anxiety disorders. According to the […]
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Mark Brezer, CEO of StraightUp Resources Inc.
December 15, 2021
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
Mining Acquisition and Development Firm StraightUp Resources Inc.’s (CSE: ST) (OTCQB: STUPF) Improves US Market Access, Celebrates Report on Ontario Site Potential
December 14, 2021
Mineral property exploration company StraightUp Resources is in an expansive stage, adding significant site acquisition rights in the United States and Peru to its Canadian portfolio and expanding its stock trading from Canada to the United States markets StraightUp recently announced that it is improving access to its U.S. stock on the OTCQB Venture Market […]
InvestorNewsBreaks – Vivos Therapeutics Inc.’s (NASDAQ: VVOS) mmRNA Device Now Covered by, Billable to Medicare
December 14, 2021
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today announced that it has received acceptance from a Centers for Medicare & Medicaid Services Pricing, Data Analysis and Coding (“PDAC”) contractor for its mmRNA (modified […]
LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Appoints Digital Transformation Expert as VP of Product, to Advance Its Lightning Network PaaS Offering
December 13, 2021
Alexandra Moxin will leverage her years of experience in product, business development and digital transformation to help expand and promote the company’s platform, lqwd.tech Ms. Moxin has previously worked in product marketing for Microsoft and is the founder and host of Advance Tech Podcast, one of the most popular podcasts in the emerging tech space […]
Friendable Inc.’s (FDBL) Robert Rositano Jr. Discusses How the Fan Pass Live Platform Provides Freedom and Control to Artists
December 13, 2021
Robert Rositano Jr.’s recent appearance on the popular Hellblazer Biz Podcast highlighted the growth of Friendable’s Fan Pass Live artist platform, and what it offers to both artists and fans The Rositano brothers have been business partners for over 30 years and have always been interested in the music industry, coming up with the Fan […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Expanding Market Reach
December 10, 2021
StraightUp Resources (CSE: ST) (OTCQB: STUPF), at the beginning of the year, broke down its 2021 exploration program into four elements: historical data review, compilation and interpretation; examining historical drill core (“ENDM” core library, Red Lake); geological mapping and sampling; and geophysical surveys. “The objective was to add new 2021 data to enhance interpretations, locate […]
InvestorNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Financing to Provide Runway for Key Milestones
December 9, 2021
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced its entry into an agreement with an investor to complete a non-brokered private placement (the “financing”) of a convertible secured subordinated debenture in the principal amount of C$5.5 million. […]
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Proceed with its Phase 2a Fibromyalgia Study Following FDA Confirmation
December 9, 2021
Tryp just announced FDA confirmation for its IND application filed in November 2021 The confirmation allows the company to proceed with its Phase 2a study on the effectiveness of psilocybin-assisted therapy among patients with fibromyalgia This clinical study will be one of the first to evaluate synthetic psilocybin for fibromyalgia in a Phase 2 study […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Fund, Support First-Ever Psychedelic Treatment Clinic at Manhattan Hospital
December 9, 2021
Company receives grant to fund clinic for marginalized, underserved NYC communities New clinic will offer psychedelic treatment with no out-of-pocket cost for individuals unable to afford the service Program’s clinicians will receive specialized training Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones in its mission […]
InvestorNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Milestones Highlight HealthTab’s Endless Diagnostic Possibilities
December 9, 2021
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has, since the company’s inception, been driven by the development of a network of point-of-care (“POC”) analyzers that run on its HealthTab(TM) software in community pharmacies, workplaces and rural areas. Earlier this year, the company signed a deal with Abbott to expand the distribution of its Affinion 2 analyzers […]
reAlpha Announces New Partnership with Title First Agency
December 9, 2021
DUBLIN, Ohio , Dec. 09, 2021 (GLOBE NEWSWIRE) — via InvestorWire – reAlpha, a cutting-edge technology company empowering everyone to invest in the $1.2 trillion short-term rental market, is proud to announce its new partnership with Title First Agency, one of the largest independent title agencies in the nation. The partnership with Title First will allow reAlpha to […]
Friendable Inc.’s (FDBL) Fan Pass Live Artist Platform December Contest Focuses on Ticketed Streams
December 8, 2021
The artist with the highest number of tickets sold in December will win a $500 cash prize Artists will be able to keep 100 percent of revenue from ticket sales Additional winning opportunities are available for artists who promote at least three events on Instagram A comprehensive guide to setting up ticketed streams is available […]
InvestorNewsBreaks – Tingo Inc. (IWBB), Data Vault Holdings Inc. Collaborate to Deliver Data Revenue to 10M Users Throughout Nigeria
December 8, 2021
Data Vault Holdings, leading the way in tokenomics and metaverse data visualization, valuation and monetization, today announced that 10 million users will be added to the Datavault(R) platform via its partnership with Tingo (OTC: IWBB), a leading agri-fintech business in Africa that has delivered significant impact with its unique rural communities-based business model. Per the […]
AmeriCann Reports Record Quarter and Fiscal Year-End Financial Results
December 8, 2021
The Company achieved positive quarterly net income and substantial EBITDA growth BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) — via InvestorWire — AmeriCann Inc. (OTCQB: ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, released financial and operational results for its fiscal year and quarter ending September 2021. Financial Overview […]
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Moving Rapidly to Progress CYB003 Toward Clinical Development
December 8, 2021
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced a confirmed scientific advice meeting with the UK Medical and Healthcare Products Regulatory Agency (“MHRA”) for the first quarter of calendar year 2022. According to the update, this program milestone brings Cybin closer to advancing its lead investigational […]
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Finishing Up Significant 2021 Calendar Year
December 7, 2021
2021 marked Mydecine’s patent application for its MYCO-003 drug candidate It also marked notable clinical trials on various aspects, including smoking cessation Mydecine also got into a 5-year research agreement with JHU for clinical research on the use of psychedelics for therapeutics These milestones have laid down the groundwork, not just for Q3 of the […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Initial Shipment of CGM Devices to MySugarWatch Licensee
December 7, 2021
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that it has completed its initial shipment of sugarBEAT(R) continuous glucose monitor (“CGM”) devices to its U.K. licensee, MySugarWatch Limited, previously DB Ethitronix Limited. According to the update, MySugarWatch will […]
FDA green lights Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Psychedelic Drug Trial for Treating Fibromyalgia, After Completing IND Process
December 6, 2021
Pharmaceutical company Tryp Therapeutics is advancing research into the ability to treat unmet medical needs by using synthetic psychedelic drug candidates generally regarded as illegal and of no practical value under federal drug standards The company is demonstrating its faith in the potential of psychedelic medicine by advancing its proprietary TRP-8802 psilocybin candidate toward Phase […]
InvestorNewsBreaks – Gage Growth Corp. (CSE: GAGE) (OTCQX: GAEGF) Announces DTC Eligibility and Closing of Sturgis Dispensary
December 3, 2021
Gage Growth Corp. (CSE: GAGE) (OTCQX: GAEGF) (d.b.a. Gage Cannabis), a leading high-quality cannabis brand and operator in Michigan, today announced that its subordinate voting shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be traded and serviced through DTC’s electronic book-entry system. […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Research and Technology Progress, Offers Corporate Update
December 3, 2021
Investment banking firm The Maxim Group reiterates ‘buy’ rating on MCURF following the company’s updates on pivotal research and technology, including The Desire Project, manufacturing of synthetic ibogaine, and the iSTRYM platform MINDCURE is focused on developing psychedelic compounds to scale science-backed and evidentiary-based mental health therapy worldwide In July, MINDCURE filed for patents on […]
StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Marks the Successful Completion of its 2021 Ferdinand Gold Project Exploration Plan With the Discovery of Multiple Targets
December 3, 2021
Groundwork exploration kicked off in August, led by Orix Geosciences The survey revealed multiple areas of high merit and potential mineralization This complements a sediment sampling conducted back in 2001 by the Ontario Geological Survey With these results, StraightUp can now execute its right to acquire 100% interest in the property In early 2021, StraightUp […]
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Switzerland Ethics Committee Approval of Pivotal Berubicin Study
December 2, 2021
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has received approval from the Switzerland Ethics Committee (swissethics) — the first approval of its kind from a European ethics committee — for its study of Berubicin. Exclusive to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Achieves Key Milestone to Secure More than 50 Signed Clients
December 2, 2021
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, today announced new contracts to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. According to the update, the new clients include a regional employer contract for behavioral health as well as a strategic partnership in the provider market […]
InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Receives Green Light from FDA for Clinical Study in Fibromyalgia
December 2, 2021
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced its receipt of confirmation from the U.S. Food and Drug Administration (“FDA”) that its review of Tryp’s Investigational New Drug (“IND”) application is complete and that the company may proceed with its clinical […]
Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2-2021 Results, Signs Global Commercial Contract with MySugarWatch DuoPack Limited
December 2, 2021
NMRD releases fiscal Q2-2021 results, provides business update Highlights include pending revenue recognition, global commercial contract with MySugarWatch DuoPack Limited, appointment of Dr. Osama Hamdy to advisory board Company operates at intersection of $59 billion Type 2 diabetes market, $50+ billion pre-diabetic market, $60 billion wearable weight loss and wellness applications sector Nemaura Medical (NASDAQ: […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Touts Highlights of ‘Transformative’ Second-Quarter Performance
December 2, 2021
Report notes significant and swift advancements in company R&D pipeline and overall business Preliminary data indicates CYB003 may provide significant treatment benefits that address limitations of oral psilocybin CYBN programs and new psychedelic chemical entities have potential to transform treatment landscape for various psychiatric and neurological conditions Q2 2021 has been a transformative quarter for […]
Cannabis Strategic Ventures Inc. (NUGS) Moving Forward to Achieve Vision of Being Top-Tier, Farm-to-Door, Premium Cannabis Company
December 2, 2021
NUGS “wasting no time” in deploying assets to launch one of California’s top vertical cannabis models Company plans to deploy another new license for establishment of indoor cultivation facility Four licenses provide regulatory backing for a series of major next steps critical to NUGS’ strategy An emerging leader in the U.S. cannabis marketplace, Cannabis Strategic […]